Device Trial Radar · NCT04984993
Clinical Investigation Using MED3000 Gel or Tadalafil Tablets in the Treatment of Erectile Dysfunction
Last checked: Nov 20, 2026Latest source record: Sep 21, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
116
Actual
Start
Sep 14, 2021
Primary completion
Jul 13, 2022
Study completion Jul 13, 2022
Sponsor
- Lead sponsor
- Futura Medical Developments Ltd.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 2, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- Male only, from 22 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
An open-label investigation using MED3000 gel or tadalafil (5 mg) tablets in the treatment of erectile dysfunction in patients from 22 to 70 years of age. Each patients will be expected to participate for up to 30 weeks. Eligible patients will be randomised to receive either MED3000 gel or tadalafil (5 mg) tablets in a 1:1 ratio.
Conditions
- Erectile Dysfunction
Interventions
MED3000 (Male)Device
Gel formulation
Tadalafil 5mg (Male)Drug
Tablets
MED3000 (Female)Device
Gel formulation
Tadalafil 5mg (Female)Drug
Tablets
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in the Erectile Function (EF) Domain of the International Index of Erectile Function (IIEF) Questionnaire, in Patients Randomised to MED3000, at Week 24Time frame: Baseline and Week 24
Locations
18 sites in 4 countries. Site status is shown where the registry gives one.
Johns Hopkins University
Baltimore, Maryland
Medical Center "Asklepii"OOD
Dupnitsa, Bulgaria
ЕТ "Аssoc. Prof. Stefan Popov - Individual Practice for Specialized Outhospital medical care for Neurology and Pscyhiatry"
Plovdiv, Bulgaria
15 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.